↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
**$5.7B** take-private pulls contracted device-manufacturing capacity into private hands as PE bets on infrastructure over innovation multiples.
$5.7 billion
taking the medical-device contract development and manufacturing organization private…
$1.6 billion
in trailing revenue and operates
19
manufacturing sites in eight countries
$14.2 billion
in medical-device CDMO acquisitions since January
KKR will acquire Integer Holdings in an all-cash transaction valued at approximately $5.7 billion, taking the medical-device contract development and manufacturing organization private by year-end. The deal removes one of the largest publicly traded CDMOs from the market and marks KKR's third significant medical-device infrastructure play in twelve months.
Integer manufactures components and finished devices across cardiac rhythm management, neuromodulation, and vascular access. The company reported $1.6 billion in trailing revenue and operates 19 manufacturing sites in eight countries. Integer's customer base includes every major cardiovascular and neurostimulation device maker. KKR did not disclose the per-share price or premium to the recent trading range. The transaction is structured as a take-private with no disclosed financing contingencies.
This acquisition extends a clear pattern. Private equity has now announced $14.2 billion in medical-device CDMO acquisitions since January, with KKR, Carlyle, and Permira each taking public manufacturers off the board. The thesis is identical across deals: public markets undervalue contract-manufacturing businesses because analysts focus on end-device innovation rather than the oligopolistic infrastructure that makes those devices possible. Integer's customer contracts span multi-year supply agreements with embedded minimum-volume commitments. The business generates cash predictably. Public shareholders demanded growth multiples. Private equity pays for contracted cash flow and operates without quarterly calls.
The timing matters. Device makers are offloading capital-intensive manufacturing to focus on R&D and regulatory pathways. The FDA's recent shift toward pre-certification frameworks and modular approvals increases the value of vertically integrated manufacturing partners who can pivot production lines without full revalidation cycles. Integer's 19 sites give it geographic redundancy and dual-sourcing capacity that customers now require in supply-chain contracts. KKR inherits contracted revenue with structural switching costs. The company has no disclosed debt-refinancing pressure through 2027.
Operators should watch for two follow-on moves. First, whether KKR consolidates Integer with any of its existing medtech holdings, particularly in electrophysiology where component overlap is high. Second, how quickly the company accelerates capacity expansions in vascular-access manufacturing, where backlog has been building since mid-2023. Any acquisition of smaller single-site CDMOs by Integer within six months would signal KKR is building a roll-up platform rather than a standalone hold. The private-equity playbook here is not cost-cutting. It is revenue acceleration through customer lock-in and modular site expansion.
The deal is expected to close in Q4 2024. Integer's executive team remains in place. No site closures have been announced.
Branded by POPS4 · proof in 60 seconds
For the principal
Watch for secondary transactions in your portfolio's device suppliers; contracted manufacturing oligopolies are repricing upward under private ownership.
For the operator
Track Integer's customer contracts for acceleration clauses; KKR will push volume commitments higher within twelve months of close.
For the house
Screen remaining public CDMOs under $3B market cap for similar take-private setups; focus on cardiac and neuro component plays.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.